electroCore to Participate in H.C. Wainwright 26th Annual Conference
electroCore, Inc. (Nasdaq: ECOR), a prominent player in the bioelectronic medicine field, is preparing to connect with investors at the 26th Annual H.C. Wainwright Global Investment Conference. This important event will be held from September 9 to September 11, 2024, in an engaging environment that encourages networking and discussions.
CEO Dan Goldberger's Keynote Participation
On September 11, Dan Goldberger, the Chief Executive Officer of electroCore, will take part in a fireside chat as a featured speaker. He will share insights about the company’s innovations and future directions in the bioelectronic medicine arena. Additionally, Mr. Goldberger will be available for one-on-one meetings that day, providing attendees with a valuable chance to interact directly with the company's leadership.
About electroCore's Innovations
electroCore is transforming the healthcare landscape with its cutting-edge non-invasive vagus nerve stimulation (nVNS) technology platform. The company is dedicated to developing medical devices that address a variety of health issues, aiming to improve both health outcomes and performance. Moreover, its consumer products leveraging nVNS technology are designed to enhance overall well-being across multiple markets, particularly in the United States and select international regions.
Exploring the Potential of nVNS Technology
The nVNS technology developed by electroCore has demonstrated potential in numerous applications, distinguishing it within the competitive bioelectronic medicine sector. With a number of clinical studies in progress, electroCore is well-positioned to highlight how its products can significantly impact patients' lives.
Investor Relations and Contact Information
For any questions regarding the conference or details about the company’s ongoing initiatives, interested individuals are encouraged to reach out using the contact information provided below.
Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
Frequently Asked Questions
1. What is the H.C. Wainwright Global Investment Conference?
The H.C. Wainwright Global Investment Conference is a major event that brings together investors and innovative companies from various sectors, including bioelectronic medicine.
2. Who is representing electroCore at the conference?
Dan Goldberger, the CEO of electroCore, will be the company’s representative at the conference.
3. What is the focus of electroCore's products?
electroCore specializes in bioelectronic medicine technologies, particularly the non-invasive vagus nerve stimulation (nVNS) aimed at managing various medical conditions.
4. How can I contact electroCore for more information?
Individuals seeking more information can reach out to electroCore's Investor Relations department by phone at (973) 302-9253 or via email at investors@electrocore.com.
5. Where can I learn more about electroCore’s technologies?
To find out more about electroCore and its offerings, you can visit the company’s official website.